Back
Keros Therapeutics Stock Predictions

How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
14
KROS
Keros Therapeutics
Last Price:
$13.57
Seasonality Move:
8.33%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compaKeros Therapeutics Stock Forecast
-
Over the next 52 weeks, Keros Therapeutics has on average historically fallen by 2.1% based on the past 5 years of stock performance.
-
Keros Therapeutics has fallen lower in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Keros Therapeutics Stock Undervalued?The current Keros Therapeutics [KROS] share price is $13.55. The Score for KROS is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Keros Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Keros Therapeutics has on average historically fallen by 2.1% based on the past 5 years of stock performance.
Keros Therapeutics Stock Rating
Sell
14
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics overpriced?
-
Keros Therapeutics has fallen lower in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Keros Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kerostx.com
52-Week Data
52-Week High:
72.37
52-Week Low:
9.12
Prediction Charts
Market Cap:
550.3M
Price in USD:
13.55
Volume:
294.2K
Beta:
1.19
Technical Analysis
SMA50:
13.85
SMA100:
12.42
SMA200:
29.55
52-Wk Change:
-69.65%
Stock Predictions
-
Is Keros Therapeutics stock public?Yes, Keros Therapeutics is a publicly traded company.
-
What is the Keros Therapeutics stock quote today?The Keros Therapeutics stock price is 13.55 USD today.
-
How to buy Keros Therapeutics stock online?You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-30 | 14.01 | 14.15 | 14.33 | 13.77 |
Jun-2 | 14.15 | 14.66 | 14.79 | 14.15 |
Jun-3 | 14.75 | 14.95 | 15.20 | 14.59 |
Jun-4 | 14.94 | 14.82 | 15.17 | 14.76 |
Jun-5 | 14.82 | 15.11 | 15.23 | 14.64 |
Jun-6 | 15.18 | 15.04 | 15.40 | 14.93 |
Jun-9 | 14.20 | 14.09 | 15.14 | 14.00 |
Jun-10 | 13.78 | 13.75 | 14.02 | 13.50 |
Jun-11 | 13.96 | 13.79 | 14.05 | 13.71 |
Jun-12 | 13.72 | 13.64 | 14.00 | 13.54 |
Jun-13 | 13.49 | 13.56 | 13.84 | 13.34 |
Jun-16 | 13.65 | 13.66 | 13.91 | 13.50 |
Jun-17 | 13.60 | 13.46 | 13.76 | 13.31 |
Jun-18 | 13.48 | 13.55 | 13.80 | 13.40 |
Keros Therapeutics Earnings
Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Keros Therapeutics Forecast Revenue Growth
Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.03 per share, an increase this year of $4.50 per share, and a decrease next year of $4.46 per share.
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.